The ‘ABC’of GABA receptors: a brief review M Chebib, GAR Johnston Clinical and experimental pharmacology and physiology 26 (11), 937-940, 1999 | 618 | 1999 |
GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology M Chebib, GAR Johnston Journal of medicinal chemistry 43 (8), 1427-1447, 2000 | 458 | 2000 |
Flavonoid modulation of GABAA receptors JR Hanrahan, M Chebib, GAR Johnston British journal of pharmacology 163 (2), 234-245, 2011 | 316 | 2011 |
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors T Bakas, PS Van Nieuwenhuijzen, SO Devenish, IS McGregor, JC Arnold, ... Pharmacological research 119, 358-370, 2017 | 280 | 2017 |
The dietary flavonoids apigenin and (−)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA receptors EL Campbell, M Chebib, GAR Johnston Biochemical pharmacology 68 (8), 1631-1638, 2004 | 191 | 2004 |
Alpha9 nicotinic acetylcholine receptors and the treatment of pain JM McIntosh, N Absalom, M Chebib, AB Elgoyhen, M Vincler Biochemical pharmacology 78 (7), 693-702, 2009 | 172 | 2009 |
GABAA receptors and the diversity in their structure and pharmacology HC Chua, M Chebib Advances in pharmacology 79, 1-34, 2017 | 170 | 2017 |
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions LL Anderson, NL Absalom, SV Abelev, IK Low, PT Doohan, LJ Martin, ... Epilepsia 60 (11), 2224-2234, 2019 | 144 | 2019 |
Modulation of ionotropic GABA receptors by natural products of plant origin GAR Johnston, JR Hanrahan, M Chebib, RK Duke, KN Mewett Advances in Pharmacology 54, 285-316, 2006 | 144 | 2006 |
The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice SP Fernandez, M Nguyen, TT Yow, C Chu, GAR Johnston, JR Hanrahan, ... Neurochemical Research 34, 1867-1875, 2009 | 129 | 2009 |
Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2 RJ Vandenberg, AD Mitrovic, M Chebib, VJ Balcar, GAR Johnston Molecular pharmacology 51 (5), 809-815, 1997 | 121 | 1997 |
α4βδ GABAA receptors are high-affinity targets for γ-hydroxybutyric acid (GHB) N Absalom, LF Eghorn, IS Villumsen, N Karim, T Bay, JV Olsen, ... Proceedings of the National Academy of Sciences 109 (33), 13404-13409, 2012 | 115 | 2012 |
The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor DH Small, D Maksel, ML Kerr, J Ng, X Hou, C Chu, H Mehrani, S Unabia, ... Journal of neurochemistry 101 (6), 1527-1538, 2007 | 112 | 2007 |
Antidepressant, anxiolytic and antinociceptive activities of constituents from Rosmarinus officinalis A Abdelhalim, N Karim, M Chebib, T Aburjai, I Khan, GAR Johnston, ... Journal of Pharmacy & Pharmaceutical Sciences 18 (4), 448-459, 2015 | 108 | 2015 |
GABAC receptors as drug targets GAR Johnston, M Chebib, JR Hanrahan, KN Mewett Current Drug Targets-CNS & Neurological Disorders 2 (4), 260-268, 2003 | 108 | 2003 |
Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant α1β2γ2L GABAA receptors SH Huang, RK Duke, M Chebib, K Sasaki, K Wada, GAR Johnston European journal of pharmacology 464 (1), 1-8, 2003 | 108 | 2003 |
GABAC RECEPTOR ION CHANNELS M Chebib Clinical and Experimental Pharmacology and Physiology 31 (11), 800-804, 2004 | 105 | 2004 |
Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory M Chebib, T Hinton, KL Schmid, D Brinkworth, H Qian, S Matos, HL Kim, ... The Journal of pharmacology and experimental therapeutics 328 (2), 448-457, 2009 | 103 | 2009 |
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism HC Chua, ETH Christensen, K Hoestgaard-Jensen, LY Hartiadi, I Ramzan, ... PLoS One 11 (6), e0157700, 2016 | 102 | 2016 |
Semisynthetic preparation of amentoflavone: a negative modulator at GABAA receptors JR Hanrahan, M Chebib, NLM Davucheron, BJ Hall, GAR Johnston Bioorganic & medicinal chemistry letters 13 (14), 2281-2284, 2003 | 98 | 2003 |